The anticipated size of the Angiogenesis Assays Market in 2022 was USD 1,972.1 million and is estimated to be USD 2,139.7 million in 2023. Increase in demand for angiogenesis assays majorly used in academic institutions and biotech companies is also contributing to the growth of this market.
Future Market Insights has mentioned in its reports that the automotive composites market will expand at a CAGR of 9.10% between 2023 and 2033, totaling around USD 5,112.2 million by 2033.
Angiogenesis is the process of the formation of new blood vessels from pre-existing vasculature where it involves the proliferation, migration, and differentiation of endothelial cells which leads to increased vascularization because this process is physiologically important for the development and wound healing and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer.
North America is considered to be a dominant region for the Angiogenesis Assay Market, owing to the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis.
| Attribute | Details |
|---|---|
| Projected Forecast Value (2022) | USD 1,972.1 million |
| Projected Forecast Value (2023) | USD 2,139.7 million |
| Projected Forecast Value (2033) | USD 5,112.2 million |
| Growth rate | 9.10% CAGR |
| Forecast period | 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global angiogenesis assays market grew at a CAGR of 7.3% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 9.1% between 2023 and 2033.
Angiogenesis occurs in response to a variety of molecular cues as generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes.
Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however, the structures that form during pathological angiogenesis are often functionally abnormal.
Major factor that is expected to augment the growth of the angiogenesis assay market during the forecast period includes the increasing number of research and development activities in this field.
Factor that is expected to hinder the growth of the angiogenesis assay market during the forecast period includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays
Increase in the Number of Research and Development Activities
Major factor that is expected to drive the growth of the angiogenesis assay market during the forecast period includes an increasing number of research and development activities in this field. Rising Research and Development spending on cancer therapeutics is another major factor that is expected to fuel market growth.
Rise in Medical Tourism in Different Regions
Other factors that are anticipated to accelerate the growth of the angiogenesis assay market during the forecast period include increasing medical tourism in some regions. Factors such as the availability of government initiatives supporting research activities and product development are also favoring market growth.
Principal Consultant
Biochemical Analysis of the Molecular Events
Major factor that is expected to hamper the growth of the angiogenesis assay market during the forecast period includes scaling up this technique, which tends to make a biochemical analysis of the molecular events mediating wound repair difficult.
Lack of Angiogenesis’ Accurate Analysis
Challenge that hinders market growth includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays currently in use.
Increase in Developed Infrastructure, High Spending Capacity as well as Strict Regulations
North America holds the major share of the market, attributed to the developed infrastructure, high spending capacity as well as strict regulations in the angiogenesis assay market with a market share of 38.1%
United States factor expected to accelerate the market growth in the region includes the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis with a market share of 43.0%. North American angiogenesis assay market is expected to expand at an 8% CAGR during the forecast period
Rise in Investments from the Manufacturers
Future Market Insights says that Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the increased investments from the manufacturers.
Asia Pacific countries including India are said to grow at a CAGR of 10.9% and China’s growth at a CAGR of 10.2% is anticipated to favor the growth of the angiogenesis assay market during the forecast period, attributed to the rising prevalence of the chronic diseases, and increasing cell-based studies in the region including Australia growing at a CAGR of 8.7% and Japan holding the value share of 5.3%.
Boost the Focus of Research and Regenerative Medicine for the Market
Europe is said to hold a market share of 29.3% after North America, where the United Kingdom and Germany are said to hold a major portion in this market where United Kingdom grows at a CAGR of 8.1% whereas Germany has a value share of 6.7%
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Angiogenesis Tube Formation Assays are said to Hold a Dominant Position
Angiogenesis tube formation assays are said to hold a major market share of 52.3% where new blood vessels will be formed from pre-existing vessels. Angiogenesis plays an important role in physiological and pathological conditions like wound healing, embryonic development, cancer growth, etc.
In-vitro Angiogenesis Application is Said to be Faring
In-vitro application angiogenesis holds a market share of 63.0% as the device is used in the measurement of protein or any other substance present in biological fluids and tissues, like blood, urine, serum, or tissue.
Hospitals are considered to be the Most in Demand
Hospitals hold a value share of 48.0% in this market as the treatment for angiogenesis assays can be taken with proper care in hospitals itself.
Some of the prominent players in the global market are-
Some of the important developments of the key players in the market are:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.10% from 2023 to 2033 |
| Market value in 2023 | USD 2,139.7 million |
| Market value in 2033 | USD 5,112.2 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | USD million for Value and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | By Product Type, By Application, By End-user, By Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa |
| Key Countries Profiled | United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel, Rest of MEA |
| Key Companies Profiled | Cell Biolabs, Inc.; Thermo Fisher Scientific; Abcam plc.; PromoCell GmbH; Merck KGaA; ATCC; Corning Incorporated; Bio-Techne; Molecular Devices, LLC; BioVision, Inc |
| Customisation Scope | Available on Request |
The market is valued at USD 2.1 billion in 2023.
The market’s CAGR from 2023 to 2033 will be 9.1%.
Cell Biolabs, Inc., Thermo Fisher Scientific, and Abcam plc are the key market players.
The market captured a CAGR of 7.3% from 2017 to 2022.
The market is estimated to reach USD 5.1 billion by 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Angiogenesis Tube Formation Assays 5.2. Microfluidic 5.3. Endothelial Adhesion 5.4. Invasion and Migration Assays 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. In Vitro Angiogenesis 6.2. In Vivo Angiogenesis 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By User 7.1. Hospitals 7.2. Specialty Clinics 7.3. Ambulatory Surgical Centers 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Cell Biolabs, Inc. 18.2. Thermo Fisher Scientific 18.3. Abcam plc. 18.4. PromoCell GmbH 18.5. Merck KGaA 18.6. ATCC 18.7. Corning Incorporated 18.8. Bio-Techne 18.9. Molecular Devices, LLC 18.10. BioVision, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Angiogenesis Assays Market
